Skip to main content

. 1994 Jan 8;308(6921):110–111. doi: 10.1136/bmj.308.6921.110

Renal disease and use of topical non-steroidal anti-inflammatory drugs.

C A O'Callaghan ¹, P A Andrews ¹, C S Ogg ¹

PMCID: PMC2539211 PMID: 8298379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Doogan D. P. Topical non-steroidal anti-inflammatory drugs. Lancet. 1989 Nov 25;2(8674):1270–1271. doi: 10.1016/s0140-6736(89)91869-2. [DOI] [PubMed] [Google Scholar]
Fellner S. K. Piroxicam-induced acute interstitial nephritis and minimal-change nephrotic syndrome. Am J Nephrol. 1985;5(2):142–143. doi: 10.1159/000166921. [DOI] [PubMed] [Google Scholar]
Murray M. D., Brater D. C., Tierney W. M., Hui S. L., McDonald C. J. Ibuprofen-associated renal impairment in a large general internal medicine practice. Am J Med Sci. 1990 Apr;299(4):222–229. doi: 10.1097/00000441-199004000-00002. [DOI] [PubMed] [Google Scholar]
Pirson Y., van Ypersele de Strihou C. Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. Am J Kidney Dis. 1986 Nov;8(5):338–344. doi: 10.1016/s0272-6386(86)80108-1. [DOI] [PubMed] [Google Scholar]
Sandler D. P., Burr F. R., Weinberg C. R. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med. 1991 Aug 1;115(3):165–172. doi: 10.7326/0003-4819-115-3-165. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES